Verified Nov 2026
Other
·
Kuopio
·
Since 1993
FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.
FinVector Oy at a glance
Revenue
$10-50M
Est. band
Employees
200-500
Founded
1993
Headquarters
Kuopio
Industries
Automotive
Electric Vehicles
Construction
Medical
Industrial Equipment
Overview
FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | Kuopio |
Employees | 200-500 |
Revenue | $10-50M (estimated) |
What FinVector Oy makes
The company provides contract manufacturing and process development services for viral-based gene therapies under cGMP conditions, with cleanroom facilities.
Latest developments
2026-07-23 — FinVector scales global gene therapy manufacturing in Finland (investinfinland.com)
2026-07-07 — 🌱 Committed to a more energy-efficient future | FinVector Oy (linkedin.com)
2026-05-27 — Yhteistyöstä vaikuttavuutta – Savonia ja FinVector rakentavat tulevaisuuden osaamista - Savonia-AMK (savonia.fi)
2025-11-11 — Biolääkeyhtiö Finvector irtisanoo 42 työntekijää Kuopion lääketehtaalta | Pohjois-Savo | Yle (yle.fi)
2025-11-06 — FinVector: Accelerating information security development with a CSOC service (loihde.com)
2025-09-26 — Finvector aloitti muutosneuvottelut – Jopa 60 työntekijää vaarassa saada potkut | Savo | Savon Sanomat (savonsanomat.fi)
Facilities
FinVector Oy is headquartered in Kuopio. Public sources also reference these locations:
Finland — finvector.com
Finland Kuopio, Finland — finvector.com
Company details
FinVector is a subsidiary of Ferring Ventures S/A, part of Ferring Pharmaceuticals, and operates with a workforce drawn from over 50 nationalities. FinVector Oy was founded in 1993, has an estimated 200-500 employees, and is headquartered in Kuopio.
Frequently asked questions
What does FinVector Oy do?
FinVector Oy is a biopharmaceutical contract manufacturer founded in 1993 and headquartered in Kuopio, Finland. The company employs 200–500 staff and operates one of Europe's gene therapy production facilities. FinVector specializes in cGMP manufacturing of viral vectors including Adenoviral, AAV, and Lentiviral types, serving clients in biopharmaceutical development and commercialization across multiple therapeutic areas.
Where is FinVector Oy headquartered?
FinVector Oy is headquartered in Kuopio.
When was FinVector Oy founded?
FinVector Oy was founded in 1993.
How big is FinVector Oy?
FinVector Oy has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
